Louisville, KY, United States of America

Amanda J LeBlanc


Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 13(Granted Patents)


Company Filing History:


Years Active: 2017-2018

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Amanda J LeBlanc: Innovator in Tissue Engineering and Myocardial Infarction Treatment

Introduction

Amanda J LeBlanc is a prominent inventor based in Louisville, KY (US). She has made significant contributions to the fields of tissue engineering and cardiovascular treatment. With a total of 2 patents, her work focuses on innovative methods for creating tissue constructs and treating myocardial infarctions.

Latest Patents

Amanda's latest patents include groundbreaking advancements in medical technology. One of her patents describes "Adipose stromal vascular fraction cell constructs," which involves creating three-dimensional tissue constructs by isolating adipose-derived stromal vascular fraction (SVF) cells. These cells are plated onto a polymer scaffold and cultured in a specific medium to promote growth. Another notable patent outlines "Methods for treating an established myocardial infarction." This application reveals techniques for treating myocardial infarctions using an epicardial construct containing SVF from adipose tissue, which is seeded onto a biocompatible substrate. This method aims to preserve microvascular function and enhance left ventricular contractile mechanisms.

Career Highlights

Amanda J LeBlanc is affiliated with the University of Louisville Research Foundation, Inc., where she continues to advance her research and innovations. Her work has garnered attention for its potential impact on regenerative medicine and cardiac health.

Collaborations

Amanda collaborates with James Beatty Hoying, who is also involved in research related to her patents. Their partnership exemplifies the collaborative spirit of innovation in the medical field.

Conclusion

Amanda J LeBlanc is a trailblazer in the realm of tissue engineering and myocardial infarction treatment. Her patents reflect her commitment to advancing medical science and improving patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…